Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction.
D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D002986:Clinical Trials as Topic; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005947:Glucose / Q000627:therapeutic use*; D005950:Glucose Solution, Hypertonic / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007263:Infusions, Parenteral; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects*; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011188:Potassium / Q000627:therapeutic use*; D011877:Radionuclide Imaging; D011897:Random Allocation; D013318:Stroke Volume / Q000187:drug effects
D005230:Fatty Acids, Nonesterified; D005950:Glucose Solution, Hypertonic; D007328:Insulin; D005947:Glucose; D011188:Potassium